cetylpyridinium chloride anhydrous has been researched along with Anemia, Fanconi in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mohseni Meybodi, A; Mozdarani, H | 1 |
| Aasen, T; Barrero, MJ; Bueren, J; Castellà, M; Consiglio, A; Garreta, E; González, F; Guenechea, G; Izpisúa Belmonte, JC; Navarro, S; Raya, A; Río, P; Rodríguez-Pizà, I; Sleep, E; Surrallés, J; Tiscornia, G; Vassena, R; Veiga, A; Verma, IM | 1 |
2 other study(ies) available for cetylpyridinium chloride anhydrous and Anemia, Fanconi
| Article | Year |
|---|---|
DNA damage in leukocytes from Fanconi anemia (FA) patients and heterozygotes induced by mitomycin C and ionizing radiation as assessed by the comet and comet-FISH assay.
Topics: Adolescent; Adult; Case-Control Studies; Child; Child, Preschool; Chromosome Breakage; Chromosomes, Human; Comet Assay; DNA Damage; Fanconi Anemia; Health; Heterozygote; Humans; In Situ Hybridization, Fluorescence; Leukocytes; Mitomycin; Radiation Tolerance; Radiation, Ionizing | 2009 |
Disease-corrected haematopoietic progenitors from Fanconi anaemia induced pluripotent stem cells.
Topics: Cell Line; Cellular Reprogramming; Fanconi Anemia; Health; Hematopoietic Stem Cells; Humans; Pluripotent Stem Cells | 2009 |